Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
The biomarker fibroblast growth factor-23 (FGF-23) has been associated with increased cardiovascular morbidity and mortality in both patients with and without type 2 diabetes. The aim of this study was to eval...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Martin H. S ørensen, Annemie S. Bojer, Niklas R. Jørgensen, David A. Broadbent, Sven Plein, Per L. Madsen and Peter Gæde Tags: Original investigation Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Study